CYSLTR2 and metastatic neoplasm: In Kaplan–Meier survival curves generated from median scoring of all primary UM cases, immunohistochemical levels of CysLT1 or CysLT2 did not demonstrate a significant association with patient survival from metastatic disease (CysLT1p = 0.122; HR 2.04; 95% CI 0.81–5.12, CysLT2p = 0.341; HR 1.15; 95% CI 0.58–2.28) (Figure 2B,E, respectively).